Trial intelligence / Profile preview

Tranexamic acid versus epsilon-aminocaproic acid in total knee prosthesis surgery

RBR-4c6s7sPhase 3Recruiting

Sponsor
Associação Evangélica Beneficente de Londrina
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in knee osteoarthritis (OA) comparing Tranexamic acid group with Epsilon-aminocaproic acid group (2 arms). Started Jul 2017; status: recruiting.

02

Drugs

tranexamic acidaminocaproic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on RBR-4c6s7s.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4c6s7s.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call